0 Yorumlar
0 hisse senetleri
3448 Views
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
- Please log in to like, share and comment!
- Biosimilar Bevacizumab Market: Is 2026 the Year Oncology Treatment Costs Drop by 70%?As of January 22, 2026, the biosimilar bevacizumab market is identifying as a transformative force in global oncology, with its 2026 valuation contributing to a sector expected to reach $2.23 billion by 2029. The 2026 landscape is defined by a steady CAGR of 7.9%, driven by the expiration of key patents for the reference biologic, Avastin, and a global mandate for cost-effective cancer care....0 Yorumlar 0 hisse senetleri 865 Views
- China Continuous Renal Replacement Therapy Market: Can Localization Bridge the Critical Care Gap?The China Continuous Renal Replacement Therapy Market has entered a phase of explosive growth in 2026, fueled by the government’s public health reform plans and a focus on repatriating complex medical procedures. Local tech giants are increasingly challenging global incumbents by producing cost-effective, high-performance machines that meet the specific demands of China's sprawling...0 Yorumlar 0 hisse senetleri 500 Views
- Natural Killer Cell Therapeutics Market: Is 2026 the Year "Off-the-Shelf" Cancer Killers Finally Outperform CAR-T?As of January 22, 2026, the natural killer cell therapeutics market is identifying as the most disruptive sub-sector of immunotherapy, with its 2026 valuation reaching approximately $571 million to $985 million depending on the inclusion of directed antibodies. The 2026 landscape is defined by a explosive CAGR of 7.2% to 40.2%, as researchers pivot toward NK cells due to their superior safety...0 Yorumlar 0 hisse senetleri 716 Views
- PD-L1 Inhibitors Market: Is 2026 the Year Immunotherapy Moves Beyond the Hospital Chair?As of January 22, 2026, the PD-L1 inhibitors market is identifying as a powerhouse of modern oncology, with its 2026 valuation reaching approximately $57.5 billion within the broader $70.8 billion PD-1/PD-L1 checkpoint inhibitor landscape. The 2026 landscape is defined by a high-velocity CAGR of 13.88% to 19.85%, spurred by the aggressive expansion of drug labels into early-stage "adjuvant"...0 Yorumlar 0 hisse senetleri 866 Views
- Revolutionizing Display Technology: Growth Outlook of the Touchscreen Controller Market“According to a new report published by Introspective Market Research, titled, Touchscreen Controller Market by Technology, Interface, and Application, The Global Touchscreen Controller Market Size Was Valued at USD 8.58 Billion in 2023 and is Projected to Reach USD 27.86 Billion by 2032, Growing at a CAGR of 13.98%.” Introduction / Market Overview The global...0 Yorumlar 0 hisse senetleri 2939 Views
- Revolutionizing Modern Living: Growth Outlook of the Smart Home Solutions MarketAccording to a new report published by Introspective Market Research, titled, Smart Home Solutions Market by Product, Technology, and Application, The Global Smart Home Solutions Market Size Was Valued at USD 60.52 Billion in 2024 and is Projected to Reach USD 331.57 Billion by 2032, Growing at a CAGR of 23.69%. Introduction / Market Overview The Smart Home Solutions Market is...0 Yorumlar 0 hisse senetleri 2531 Views
- Scaffold Technology Market: Enabling Next-Generation Tissue Engineering and Regenerative MedicineAccording to a new report published by Introspective Market Research, titled, Scaffold Technology Market by Type, Application, and End User, The Global Scaffold Technology Market Size Was Valued at USD 2.0 Billion in 2023 and is Projected to Reach USD 6.6 Billion by 2032, Growing at a CAGR of 14.2%. Introduction / Market Overview The global Scaffold Technology Market is...0 Yorumlar 0 hisse senetleri 2707 Views
- Soft Mist Inhalers Market: Is 2026 the Year the "Aerosol Cloud" Replaces the Propellant?As of January 22, 2026, the soft mist inhalers market is identifying as the fastest-growing segment of the respiratory drug delivery landscape, with its 2026 valuation reaching approximately $3.32 billion. The 2026 landscape is defined by a robust CAGR of 7.9% to 14.3%, as these devices gain significant traction over traditional pressurized metered-dose inhalers (pMDIs) and dry powder inhalers...0 Yorumlar 0 hisse senetleri 845 Views
- Toxicology Drug Screening Market: Is 2026 the Year AI Finally Eradicates False Positives in the Workplace?As of January 22, 2026, the toxicology drug screening market is identifying as a pivotal sector in global health and safety, with its 2026 valuation reaching approximately $6.68 billion for screening systems alone, while the broader drug screening market is estimated at over $22.5 billion. The 2026 landscape is defined by a robust CAGR of 7.1% to 9.9%, driven by the urgent need to detect...0 Yorumlar 0 hisse senetleri 743 Views
Arama Sonuçları
© 2026 Friendori – Building Stronger Connections, One Friend at a Time!
Turkish